Immunoscintigraphy in the follow-up of patients operated on for carcinoma of the sigmoid and rectum
Authors:
- A. RendaARA. Renda
- M. SalvatoreMSM. Salvatore
- M. SavaMSM. Sava
- R. LandiRLR. Landi
- S. LastoriaSLS. Lastoria
- L. CoppolaLCL. Coppola
- J. SchlomJSJ. Schlom
- D. ColcherDCD. Colcher
- G. ZanniniGZG. Zannini
- 1 September 1987
- journal article
- conference paper
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 30 (9) , 683-686
Abstract
Thirty patients who had curative surgery for sigmoid and rectal carcinoma were studied by immunoscintigraphy using a new monoclonal antibody: B72.3 radiolabeled with Iodine-131 (I-131) or Indium-111 (In-111). Results were compared with other conventional diagnostic procedures such as computed tomography, ultrasound, endoscopy, and tumor markers. Seven patients had local recurrences and/or distant metastases. Immunoscintigraphy identified all local recurrences (five cases) that were confirmed by CT and was able to localize three of five metastases (two false-negatives). Furthermore, immunoscintigraphy also recorded a false-positive. Preliminary use of B72.3 shows good potential for the evaluation and detection of neoplastic sites.Keywords
This publication has 3 references indexed in Scilit: